Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
alzheimer's disease
2
×
biotech
boston blog main
boston top stories
clinical trials
crispr
2
×
deals
2
×
life sciences
national blog main
san francisco blog main
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
allergan
antibiotics
axial spondyloarthritis
bausch health
biogen
boston
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
cluster headache
cynthia collins
detroit blog main
detroit top stories
diagnostics
digital health
dihydroergotamine
dimitry nuyten
drug prices
eddingpharm
What
abbvie
alliance
approval
bio
biogen’s
biopharmaceutical
biotech
companies
convo
drug
earlier
editas
editing
exits
experimental
failures
gene
genetic
littered
medicines
nash
new
news
pact
partnership
price
pruning
remains
research
returning
rights
road
roundup
strategy
talk
terminated
treatment
Language
unset
Current search:
crispr
×
" alzheimer's disease "
×
deals
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
